Oev Partners

OEV Partners exists to support and serve the emerging new industries, fresh thinking, and revolutionary mental health treatments now made possible by global drug law reform. We believe that new treatments using psilocybin, MDMA, LSD, ibogaine and ketamine, will soon be as indispensable in mental healthcare as anaesthetic or antibiotics are in surgery – and so do increasing numbers of lawmakers, medics, and investors worldwide. Our goal is to help uproot and rightly discard outdated policies and to help this dynamic and complex sector grow responsibly through research-based advocacy and campaigning, smart media consultancy, and original content creation. That means putting the needs of patients first – in everything we do, from advocacy and campaigning to education, continuous improvement and service design to ensure that services are designed with people at their heart and as many people as possible benefit as treatments and therapies come online.